T1	Condition 0 17	colorectal cancer
T2	Qualifier 18 52	above to 12 cm from the anal verge
R1	Has_qualifier Arg1:T1 Arg2:T2	
T3	Qualifier 54 66	unresectable
T4	Qualifier 67 78	synchronous
T5	Condition 79 89	metastases
R2	Has_qualifier Arg1:T5 Arg2:T4	
R3	Has_qualifier Arg1:T5 Arg2:T3	
T6	Procedure 116 128	chemotherapy
T7	Condition 94 111	contraindications
T8	Negation 91 93	no
R4	Has_negation Arg1:T7 Arg2:T8	
R5	AND Arg1:T7 Arg2:T6	
T9	Condition 141 166	peritoneal carcinomatosis
T10	Negation 130 137	absence
T11	Condition 168 190;198 208	central nervous system metastasis
T12	Condition 193 208	bone metastasis
*	OR T11 T12 T9
T13	Scope 141 208	peritoneal carcinomatosis, central nervous system o bone metastasis
R6	Has_negation Arg1:T13 Arg2:T10	
T14	Measurement 230 234	ECOG
T15	Value 235 238	= 2
T16	Measurement 211 229	performance status
*	OR T14 T16
T17	Measurement 240 274	Eastern Cooperative Oncology Group
R7	Subsumes Arg1:T14 Arg2:T17	
T18	Scope 211 234;240 274	performance status ECOG Eastern Cooperative Oncology Group
R8	Has_value Arg1:T14 Arg2:T15	
T19	Qualifier 277 289	uncontrolled
T20	Temporal 290 301	concomitant
T21	Condition 302 356	medical conditions that may compromise to chemotherapy
R9	Has_temporal Arg1:T21 Arg2:T20	
R10	Has_qualifier Arg1:T21 Arg2:T19	
T22	Qualifier 370 381	symptomatic
T23	Condition 382 397	cardiac disease
T24	Qualifier 358 369	significant
R11	Has_qualifier Arg1:T23 Arg2:T24	
R12	Has_qualifier Arg1:T23 Arg2:T22	
T25	Condition 403 412	pregnancy
T26	Observation 416 429	breastfeeding
*	OR T26 T25
T27	Negation 399 402	not
T28	Scope 403 429	pregnancy or breastfeeding
R13	Has_negation Arg1:T28 Arg2:T27	
